Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Glaxosmithkline Plc (GSK)

2014-12-18@15:00:58 ET
Draper Wins GSK Funding for Smaller, Smarter Implantable Devices (PRW)

2014-12-18@13:48:08 ET
GlaxoSmithKline PLC (GSK) Trading Near $42.59 Resistance Level (FBM)

2014-12-18@05:15:26 ET
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2014 (MTO)

2014-12-18@05:09:38 ET
Osteosarcoma - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:58:44 ET
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:42:22 ET
Acne Vulgaris - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:24:53 ET
Malaria - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:24:32 ET
Metastatic Melanoma - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:13:59 ET
Pruritus - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:03:02 ET
Mild Cognitive Impairment - Pipeline Review, H1 2014 (MTO)

2014-12-17@14:04:41 ET
GlaxoSmithKline PLC (GSK) Trading Near $42.91 Resistance Level (FBM)

2014-12-17@09:50:46 ET
Tuberculosis on the rise globally, second most infectious killer disease- WHO (ABW)

2014-12-17@09:05:00 ET
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan (PRN)

2014-12-17@08:41:15 ET
Three-Letter Domain Names Provide Instant Brand Recognition and Credibility (PRW)

2014-12-17@08:26:28 ET
Salix Pharmaceuticals has the Best Relative Performance in the Pharmaceuticals Industry (SLXP, MDCO, SNY, RPRX, GSK) (F70)

2014-12-17@07:38:09 ET
Global & USA Transdermal Drug Delivery Market to 2017 (MTO)

2014-12-16@18:49:29 ET
Off the track Interruption of Ebola vaccine (ABW)

2014-12-16@17:10:14 ET
Dinesh joins Access Plc Board (ABW)

2014-12-16@13:38:00 ET
Global Transdermal Drug Delivery Market to 2017: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation (PRN)

2014-12-16@12:35:06 ET
Potential GlaxoSmithKline PLC (GSK) Trade Has 3.75% Downside Protection (FBM)